HopeStage
Back to all studies
CompletedNCT03204305

Brain Imaging of Cannabinoid Receptors in Women Who Use Cannabis

About this titleRead the official source — NCT03204305
Medication studyAges 18–45United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 45 years.

Listed locations
BaltimoreSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 14, 2017
Recruitment status
Completed
Enrollment listed in the registry
28
Sponsor
Johns Hopkins University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 18 Years to 45 Years
Official registry ID
NCT03204305
Official title
Show the full official title

Brain Imaging of Cannabinoid Receptors in Women

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Johns Hopkins University, a university.

Did this study involve medication?

Yes. The study involved medication, including 11C-OMAR and Cannabis.

Who was this study for?

Listed age limits: 18 years to 45 years.

Want to explore more studies?

Explore studies